Here participants in the ACR’s Rheum With a (re)View program discuss how its mentors provided them with skills and knowledge that benefit their careers and rheumatology as a community.
Search results for: hospital
Global Summit Addresses Worldwide Rheumatology Workforce Challenges
Rheumatology workforce challenges are a global concern. Many challenges, especially the lack of trained rheumatology clinicians, are similar among countries and regions of the world, while others differ. The 2024 ACR Global Summit session on workforce featured a discussion by representatives of regional rheumatology organizations and the ACR addressing issues central to developing and retaining…
Potential Biologic Drug Treatment for IgG4-RD Identified
Inebilizumab reduces the risk of immunoglobulin G4-related disease (IgG4-RD) flares and increases the likelihood of flare-free, complete remission at one year, a recent study shows.1 The randomized, doubleblind, placebo-controlled MITIGATE trial showed that inebilizumab reduced the risk of IgG4-RD symptoms by 87%, compared with placebo. About IgG4-RD IgG4-RD is chronic, rare condition that has, so…
The Transition from a Rheumatology Fellowship to Private Practice
The transition from being a rheumatology fellow to being in private practice is significant. As I reflect on the past two years, I want to share my observations and begin a conversation about how to prepare rheumatology fellows for careers as practicing rheumatologists. The difference between learning about rheumatology and practicing rheumatology is nuanced. Upon…
Rheuminations: Lessons from 5 Years of COVID-19
My children were playing in the car the other day and pulled open the glove box. Inside, they found a brown paper bag with my last name “KUMAR” in black Sharpie and a red sticker that read, “Do not lose. No replacements available.” It wasn’t long before the kids tore that bag apart to find…
Getting to Know Natasha Ruth, MD, MS: New Division Directors Committee Chair
In her latest volunteer role with the ACR, Natasha Ruth, MD, MS, shares her plans for the Division Directors Committee and how she’s equipped to achieve these goals.
A&R Editor-in-Chief Daniel H. Solomon, MD, MPH, Reflects on the Journal, His Role & Its Future
New clinical features, opinion pieces and much more—outgoing Arthritis & Rheumatology Editor-in-Chief Daniel H. Solomon, MD, MPH, discusses how the journal has evolved and where it’s going.
My Six Cents: How to Help a Patient Feel Seen & Heard
Compassion, clear communication, empathy and more—Samantha C. Shapiro, MD, provides practical advice on how to connect with your patients during appointments.
Ekemini A. Ogbu, MD, MSc, FAAP, Leads the Pediatric Rheumatology Committee
The new chair of the ACR’s Pediatric Rheumatology Committee, Ekemini A. Ogbu, MD, MSc, FAAP, describes how helping children and families navigate complex care brings a sense of fulfillment, purpose and “just joy.”
Deucravacitinib Promising for PsA
Results from two studies found that deucravacitinib improved the signs and symptoms of patients with psoriatic arthritis who were biologic disease-modifying anti-rheumatic drug naive and those previously treated with a tumor necrosis factor α inhibitor.
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 328
- Next Page »